News & Events

  • Technology Innovation Momentum -Audited annual financial statements have been published

    In accordance with the Partnership Agreement of the Technology Innovation Momentum our first audited annual financial statements, as well as a short overview of the different projects and their respective progress is now available in our MF website (investor's login is required).

    01/04/2015
  • Kadimastem to Collaborate with Professor Shimon Efrat of Tel Aviv University, to Accelerate the Development of Diabetes Cell Therapy

    Under the agreement, the company will conduct joint research with Prof. Shimon Efrat in the field of cell therapy for diabetes, based on the technology developed by Kadimastem, and the extensive experience accumulated by Prof. Efrat and his TAU research team.

    27/01/2015
  • The nanoparticles coming to attack cancer

    Quiet Therapeutics’ specially coated nanoparticles act like Trojan Horses entering cancer cells undetected and then killing them.

    05/01/2015
  • Second Round of Momentum Fund Investments

    Tel Aviv, 14 December, 2014, Ramot at Tel Aviv University Ltd. (Ramot), the University’s technology transfer company, today announced it has completed the selection process for the second round of project funding by the Technology Innovation Momentum Fund ("Momentum Fund").
    The Momentum Fund, with an oversubscribed level of investment of $23.5 million, invests in promising breakthrough technologies in a wide range of fields, including pharmaceuticals, healthcare, high-tech and the physical sciences.

    14/12/2014
  • Untold News Awards $10,000 (U.S.) Each to Israeli Inventors

    It was announced today that Israeli Professors Dan Peer, Shlomo Magdassi, and Engineer Idan Tobis will be awarded $10,000 (U.S.) each at the inaugural Untold News Awards tonight at the Harmonie Club in New York City. The winners were submitted by prestigious institutions, including Tel Aviv University, Weizmann Institute of Science, and Technion Israel Institute of Technology, amongst others, to a jury of leaders, including Mr. David Schizer, former Dean of Columbia Law School; Dr. Barry Coller, Chief Medical Officer, Rockefeller University; Tony Tether, former Director of DARPA; and Heidi Jacobus, Chairman and CEO of Cybernet Systems.

    12/11/2014
  • Eurocontrol Technics Group Inc. entered into a Term Sheet agreement with Ramot

     Eurocontrol Technics Group Inc. (TSX Venture: EUO) (“Eurocontrol” or the “Company”), a Canadian public company specializing in the acquisition, development and commercialization of innovative energy security, authentication, verification and certification technologies for numerous vertical markets, is pleased to announce that it has entered into a Term Sheet agreement with Ramot at Tel Aviv University for the rights to a new patented technology focused on Nano imprinting security and authentication.

    31/10/2014
  • Research Agreement signed with Eurocontrol Technics Group Inc.

    Global Fluids International S.A. ("GFI") has entered into a sponsored research agreement with Ramot at Tel Aviv University focusing on the University's mandate to liaise with industry to bring promising scientific discoveries to commercialization. Renowned chemist Professor Fernando Patolsky will be leading the sponsored research project focused on a novel approach to fuel marking. GFI will have a first right of opportunity for the licencing and commercialization of the technology that is resulted from the sponsored research project.

    03/09/2014
  • IPO Names TAU as one of Top 100 Patenting Universities

    The Intellectual Property Owners (IPO) recently published a list of the top 100 universities worldwide granted U.S. patents in 2013.

    24/07/2014
  • Ramot, the Tel Aviv University Technology Transfer Company, Announces First Round of Momentum Fund Investments

    Ramot at Tel Aviv University Ltd. (Ramot), the University’s technology transfer company, today announced it has completed the selection process for the first round of project funding by the Technology Innovation Momentum Fund ("Momentum Fund"). Of the more than 60 applications submitted, six projects were selected with an approved budget of approximately five million NIS. Pending successful completion of milestones, funding of the selected projects can potentially increase to more than 20 million NIS. The next call for proposals is scheduled for Q3-2014 for a selection process to take place in Q4-2014.

    08/04/2014
  • IP Strategy: The Key to Powerful Patents Seminar

    We are delighted to invite you to the first meeting of 2014 Ramot seminar series “From Academy to Industry” to be held on March 30.
    We will explore how to make your patents strong and how to use patent strategy, in advance of filing, to accomplish your critical goals.

    12/03/2014
  • Nano israel 2014

    Come visit us at the 4th International Nanotechnology Conference & Exhibition.
    March 24-25, 2014 David Interconinental Hotel, Tel Aviv

    04/03/2014
  • BrainStorm Receives United States Patent Office Notice of Allowance for its Stem Cell Technology

    BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has received a Notice of Allowance from the U.S. Patent Office for its "Isolated Cells and Populations Comprising Same for the Treatment of CNS Diseases" (serial number 11/727,583) patent application.

    13/01/2014
  • Ramot, Tel Aviv University Tech Transfer, executes first closing of $17 million-round for Technology Innovation Momentum Fund

    SanDisk joins Tata as an investor

    Tel Aviv, 24 November, 2013: Ramot at Tel Aviv University Ltd. (Ramot), the University’s tech transfer company, today announced it has executed first closing of $17 million for its Technology Innovation Momentum Fund (the "Momentum Fund"). The Momentum Fund will invest in promising breakthrough technologies in a wide range of fields, including pharmaceuticals, healthcare, high-tech and physical sciences.
    Having completed first closing, the fund is expected to become operational shortly through its three expert scientific committees, which will review selected TAU technologies for funding commencing Q12014.

    24/11/2013
  • New protein could replace antibiotics

    Haaretz 13/11/2013

    Dr. Udi Qimron and his team has succeeded in isolating a protein that kills bacteria, in what is aa first step toward developing a substitute for antibiotics...

    14/11/2013
  • International Medical Innovation Technology 2025

    You are cordially invited to participate in the International Medical Innovation Technology 2025 Conference, the 2nd TAU/UCI meeting dedicated to medical technology. The conference will take place on November 20-21, 2013, at Tel Aviv University, Tel Aviv, Israel.
     
    Join us as we envision the medical innovation technology of the future.
    Please register as soon as possible due to limited seating.

    06/11/2013
  • Rosetta Genomics’ Announces Sponsored Research Agreement with Ramot at Tel Aviv University

    Joint Development of Nano-carrier Delivery System for miR Mimetic Technology to Treat Cancer to be Partially Funded by Israel’s Office of the Chief Scientist

    31/10/2013
  • 13/10/2013 - Industry-Academy Symposium in CNS

    An opportunity to seize! Come meet in person world’s leading brain experts!

    Jeffrey S. Nye, MD, PhD, Vice President & Global Head Neuroscience External Innovation from Janssen Pharmaceutical Companies of Johnson & Johnson
    and
    Professor Ed Boyden, Development Professor of Research in Education
    Associate Professor of Media Arts and Sciences, Benesse Career, MIT

     

    03/10/2013
  • EU PRIZE FOR WOMEN INNOVATORS 2014

    Apply now to get a chance of winning one of the three prizes!
    The European Commission has launched the 2nd edition of the EU Prize for
    Women Innovators. The competition is open until 15 October 2013!
    The EU Prize for Women Innovators aims to raise public awareness about the
    need for more innovation and more women innovators. It will reward three
    women who have developed outstanding innovations and brought them to
    market.

    15/09/2013
  • DSIT and Tel Aviv University Collaborate to Win Development Grant

    DSIT Solutions Ltd., a subsidiary of Acorn Energy, Inc. (NASDAQ: ACFN), disclosed today that the company and Ramot, the technology transfer company of Tel-Aviv University, were jointly awarded a grant from MEIMAD.

    03/09/2013